EFFICACY AND SAFETY OF FILGOTINIB AS INDUCTION AND MAINTENANCE THERAPY FOR CROHN’S DISEASE: RESULTS FROM THE PHASE 3 RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED DIVERSITY1 STUDY
Severine Vermeire 1
David T. Rubin 2
Mamoru Watanabe 3
Stefan Schreiber 4
Rajiv Mehta 5
Xavier Roblin 6
Mark C. Genovese 7
Tomasz Masior 8
Rahul Barron 8
Franck-Olivier Le Brun 8
Silvio Danese 9, 10
1 UZ Leuven, Leuven, Belgium
2 Inflammatory Bowel Disease Center, University of Chicago Medicine, Chicago, United States
3 Tokyo Medical and Dental University, Tokyo, Japan
4 University Hospital Schleswig-Holstein, Kiel, Germany
5 Surat Institute of Digestive Sciences Hospital, Surat, India
6 University Hospital of Saint-Étienne, Saint-Étienne, France
7 Gilead Sciences Inc., Foster City, United States
8 Galapagos GmbH, Basel, Switzerland
9 IRCCS Hospital San Raffaele, Milan, Italy
10 Vita-Salute San Raffaele University, Milan, Italy
Topic
Endoscopy, IBD
Session
Hit the road JAK: Part 1
Conference
UEG Week 2023
Citation
United European Gastroenterology Journal 2023; 11 (Supplement 8)
Login to access library content
Do you need help setting up your myUEG account?
Contact us at [email protected]